Ausgabe 6/2014
Inhalt (7 Artikel)
Treatment Optimization in Patients Co-Infected with HIV and Mycobacterium tuberculosis Infections: Focus on Drug–Drug Interactions with Rifamycins
Mario Regazzi, Anna Cristina Carvalho, Paola Villani, Alberto Matteelli
Sex Differences in the Pharmacokinetics of Antidepressants: Influence of Female Sex Hormones and Oral Contraceptives
Valérie A. Damoiseaux, Johannes H. Proost, Vincent C. R. Jiawan, Barbro N. Melgert
Consequences of Renal Failure on Non-Renal Clearance of Drugs
Laure Lalande, Bruno Charpiat, Gilles Leboucher, Michel Tod
Population Pharmacokinetics and Prediction of Dopamine D2 Receptor Occupancy After Multiple Doses of RBP‐7000, a New Sustained‐Release Formulation of Risperidone, in Schizophrenia Patients on Stable Oral Risperidone Treatment
Celine M. Laffont, Roberto Gomeni, Bo Zheng, Christian Heidbreder, Paul J. Fudala, Azmi F. Nasser
Pharmacokinetics of Indomethacin in Pregnancy
Erik Rytting, Tatiana N. Nanovskaya, Xiaoming Wang, Daria I. Vernikovskaya, Shannon M. Clark, Marlo Cochran, Susan M. Abdel-Rahman, Raman Venkataramanan, Steve N. Caritis, Gary D. V. Hankins, Mahmoud S. Ahmed
Evidence-Based Morphine Dosing for Postoperative Neonates and Infants
Elke H. J. Krekels, Dick Tibboel, Saskia N. de Wildt, Ilse Ceelie, Albert Dahan, Monique van Dijk, Meindert Danhof, Catherijne A. J. Knibbe
Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies
Antoine Tarral, Séverine Blesson, Olaf Valverde Mordt, Els Torreele, Daniela Sassella, Michael A. Bray, Lionel Hovsepian, Eric Evène, Virginie Gualano, Mathieu Felices, Nathalie Strub-Wourgaft